Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

The SA Pump Terminator article is as relevant

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Its_lose_not_loose Member Profile
 
Followed By 7
Posts 5,754
Boards Moderated 0
Alias Born 09/11/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2020 4:11:11 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/22/2020 6:02:22 AM
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2using Human Coronavi... InvestorsHub NewsWire - 5/20/2020 6:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/19/2020 5:15:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 5:01:26 PM
NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses InvestorsHub NewsWire - 5/12/2020 7:02:12 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/1/2020 3:39:49 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/3/2020 6:01:26 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/24/2020 5:02:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/20/2020 3:15:50 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 2/19/2020 6:04:12 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/14/2020 5:54:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/11/2020 4:31:30 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 2/5/2020 4:22:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/28/2020 6:11:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/27/2020 5:12:40 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/27/2020 12:12:19 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/24/2020 4:13:38 PM
Prospectus Filed Pursuant to Rule 424(b)(1) (424b1) Edgar (US Regulatory) - 1/24/2020 6:03:05 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/10/2020 6:01:05 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/8/2020 5:15:55 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/7/2020 6:02:23 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 1/2/2020 12:40:33 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/23/2019 12:52:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 4:47:27 PM
Its_lose_not_loose   Thursday, 10/26/17 03:52:11 PM
Re: None
Post # of 143815 
The SA Pump Terminator article is as relevant today as it was in 2014. I never read the comments before but in retrospect, they are quite funny. The defense of Seymour, Diwan, NNVC & Menon reach a fever pitch as the commentators attempt to belittle the validity and prescient accuracy of the PT article and those who would dare speak against NNVC and its principals.

https://seekingalpha.com/article/2010691-nanoviricides-house-of-cards-with-minus-80-percent-downside-strong-sell-recommendation

Leif Smith
Comments (11) |+ Follow |Send Message
"Is it really impossible to find an independent lab to test your drugs that is not owned and run by a company insider?"
No, it's not impossible:
http://bit.ly/1eml9b7
11 Feb 2014, 09:24 AM Report Abuse Reply4Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Is it essential or do you work only with strangers?
11 Feb 2014, 01:09 PM Report Abuse Reply1Like

FORZANANO
Comments (1) |+ Follow |Send Message
Great picture Leif!
What's happening to our favorite stock?
11 Feb 2014, 03:32 PM Report Abuse Reply0Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
Interestingly, "NanoViricides, Inc. Responds to Baseless Seeking Alpha Article"
http://bit.ly/MJsvzo
11 Feb 2014, 07:38 PM Report Abuse Reply4Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Any new readers just move on down the comments and almost every charge is disputed and totally destroyed. It was just a bear raid huge short position built prior to attack article and covered 2 days after publication! That says it all they slammed took the money and ran. The negative comments are part of the raid, don't be fooled by the alarmists it's their game and its obvious.
16 Feb 2014, 10:37 AM Report Abuse Reply2Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Company posted Presidents letter to stockholders that completely refutes this bear hit piece. READ IT. And relax its going to be a huge winner in the stock market. They will be testing AND complete human testing, offshore, by end 2014. This article is full of misleading hype tonget holders to sell!
13 Mar 2014, 07:47 AM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Anyone who just read this defamatory article should immediately read the April 16 news release on NNVC it is an international award honoring and recognizing the management and original scientist as the most important nano scientist in THE WORLD plus it up dates on FDA trial requirements etc it put this slam piece right in the garbage where it was born and should have stayed.
17 Apr 2014, 06:58 PM Report Abuse Reply3Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
The reality gets better and better amazing this article was allowed the light of day! Buy the stock and enjoy the rocket ride as this is going to be huge and sooner than the street thinks.
17 Apr 2014, 07:01 PM Report Abuse Reply1Like

sethbru, Contributor
Comments (51) |+ Follow |Send Message
sleuth,
I agree! Who are you going to believe - an anonymous Internet blogger who refers to himself as Pump Terminator or professionals who recognize the trailblazing strides this company is making? NNVC is on the verge of providing to the World the next "penicillin-like" class of drugs. BTW, we will probably not hear again from the manipulator known as Pump Terminator as SA is being sued to reveal his/her identity, and evidence of a new and large short position which was opened just before publishing this article is not helping their defense.
18 Apr 2014, 10:40 AM Report Abuse Reply2Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Look at the power point presentation on the company's web site . It will answer all the points brought up in this article and save you a lot of time.
08 Jun 2014, 05:57 PM Report Abuse Reply0Like

YUU WU
Comments (8) |+ Follow |Send Message
There might be some big pharma behind the attacks on NNVC. I have been observing this stock for a while. They secured their independent ownership through a few layers of security to avoid a hostile takeover. The competition is so alarmed and nervous about NNVC's novel solutions of killing viruses that they decided to deploy ugly play against its management. The fight is just starting. They will do anything in their power to derail potential success of NNVC. They will initiate more bad press coverage (the recent New Yorker Observer's article is a joke and Duff McDonald just copies PT). But PT started barking again with the assistance of Rawnoc from Investor'sHub. They all put absolutely no merits and science behind their attacks, just pure speculation. I am surprised of the judge's verdict protecting identity of the scammer. If you are a legitimate player here do not be afraid to identify yourself. I do not believe at all of your pure intentions to protect investors from NNVC's fraud. Your tone and language are so vicious, PT, that one day you will just suffocate by your own bitterness and misery.
30 Jun 2014, 06:30 PM Report Abuse Reply2Like

Sharif Galal
Comments (103) |+ Follow |Send Message
We're getting pretty close to the end of 2014 here...
22 Oct 2014, 08:11 PM Report Abuse Reply1Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
Lets not forget that CTIX has been promoted by offshore boiler rooms!
http://bit.ly/1hQPqDf
11 Feb 2014, 09:29 AM Report Abuse Reply3Like

jsiebel720
Comments (318) |+ Follow |Send Message
I just checked your link bashing CTIX. Dyman Associates is an investment company & no where on its website does it mention CTIX, let alone any other individual stocks. There is no talk on Dyman on Yahoo Message Boards or SA. Their drugs may not prove to work, but there is absolutely no evidence that they are run like NNVC. This morning's price action proves that.
11 Feb 2014, 09:45 AM Report Abuse Reply4Like

bio.bobby
Comments (554) |+ Follow |Send Message
http://bit.ly/MJ0iIQ
seems pretty clear someone think dyman is pumping ctix
11 Feb 2014, 03:56 PM Report Abuse Reply1Like

jsiebel720
Comments (318) |+ Follow |Send Message
Show me the evidence.
11 Feb 2014, 06:20 PM Report Abuse Reply1Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
He did. He gave you a link to the Swedish Financial Regulatory Authority report on the boiler room. CTIX is otcbb reverse merger boiler room garbage plain and simple.
11 Feb 2014, 06:44 PM Report Abuse Reply3Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
BuyersStrikeWP...If in fact, there was a promotion, it wasn't paid for by the company. Leo has made it clear he doesn't pay for promotions. The only thing he does is send out shareholder newsletters or pr's.
11 Feb 2014, 08:43 PM Report Abuse Reply3Like

jsiebel720
Comments (318) |+ Follow |Send Message
That link was garbage, & if that's "evidence", then its as weak as it gets. Again, I went to the Dyman website & there was no evidence they were "pumping" CTIX. If anyone has gotten a "pumping" call from Dyman, I would like to know about it. That Finnsih website had a 1 line blip, presenting or stating no evidence. As far as the company is concerned, I'll wait & see how the drugs test out. If CTIX had been "pumped" by an outside entity, it would have been posted all over the Yahoo message board months ago.
12 Feb 2014, 04:44 AM Report Abuse Reply1Like

Pump Terminator, Contributor
Comments (5) |+ Follow |Send Message
Author’s reply » nice work buyer strike.
12 Feb 2014, 11:10 PM Report Abuse Reply1Like

jsiebel720
Comments (318) |+ Follow |Send Message
No; Not nice work; CTIX is not the same as NNVC...& Just so everyone can see it, here the exact "quote" from the Swedish version of the SEC (which I hope they are better than)....
Finansinspektionen (the Swedish Financial Supervisory Authority) has today published this statement in order to warn investors against dealing with unauthorised firms.
Dyman Associates has not received authorisation from Finansinspektionen and therefore is not entitled to provide financial services in Sweden. Finansinspektionen has not received any notification of cross-border activities from other EEA countries.
Representatives from Dyman Associates contact Swedish investors through unsolicited telephone calls and offer them to buy holdings of shares in a American OTC companies such as Cellceutix.
Dyman Associates has a website (http://bit.ly/1lK6iO6) using the following contact information:
10-1, Roppongi 6-chom
Minato-ku Tokyo
106-6114
Tel: <span class="skype_c2c_print... (03) 4579 5906</span><span class="skype_c2c_conta... dir="ltr" tabindex="-1" onmouseover="SkypeClic... event)" onmouseout="SkypeClick... skype_menu_props="{"numberToCall":"+81345795906","isFreecall":false,"isMobile":false,"isRtl":false}"><span class="skype_c2c_highl... dir="ltr" skypeaction="skype_dro... class="skype_c2c_textarea_span"><img class="skype_c2c_logo_... src="resource://skype_ff_extension-at-jetpack/skype_ff_extension/data/call_skype_logo.png"><span class="skype_c2c_text_... (03) 4579 5906</span><span class="skype_c2c_free_...
Fax: +81 (03) 6800 2401
E-post: contactus@dymanassocia...
27 Avenue de I’Opera
75001 Paris
Tel: <span class="skype_c2c_print... 33 (0)1 53 01 27 08</span><span class="skype_c2c_conta... dir="ltr" tabindex="-1" onmouseover="SkypeClic... event)" onmouseout="SkypeClick... skype_menu_props="{"numberToCall":"+33153012708","isFreecall":false,"isMobile":false,"isRtl":false}"><span class="skype_c2c_highl... dir="ltr" skypeaction="skype_dro... class="skype_c2c_textarea_span"><img class="skype_c2c_logo_... src="resource://skype_ff_extension-at-jetpack/skype_ff_extension/data/call_skype_logo.png"><span class="skype_c2c_text_... 33 (0)1 53 01 27 08</span><span class="skype_c2c_free_...
Fax: + 33 (0)1 53 01 35 52
E-post: contactus@dymanassocia...
If anyone knows any investors in Sweden who have received any solicitation from Dyman, please post. TY
13 Feb 2014, 01:00 PM Report Abuse Reply0Like

Hope4Future
Comments (291) |+ Follow |Send Message
Oh Sharon, please.
14 Feb 2014, 12:36 PM Report Abuse Reply0Like

Pump Terminator, Contributor
Comments (5) |+ Follow |Send Message
Author’s reply » wow, that is an incredible find BuyersStrike
01 Apr 2014, 06:46 PM Report Abuse Reply1Like

Ruk
Comments (190) |+ Follow |Send Message
Well written and thought provoking article, I have started to follow your postings. I have been burnt in the past by companies similar to the ones you are uncovering. I commend you for your work, you are doing service for SA readers, as well as making money.
However based on your article , I tried to short NNVC through Schwab this morning and received a message when I tried to place the trade that the stock was ineligible for a short.
How did you short it ?
11 Feb 2014, 09:38 AM Report Abuse Reply8Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
@Ruk Options are available on NNVC, which is unusual for companies of this level of sleaze.
11 Feb 2014, 09:51 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Which other postings I want to research what else he's done.
11 Feb 2014, 01:11 PM Report Abuse Reply2Like

Dabigragu
Comments (2) |+ Follow |Send Message
"Follow his postings"? This is the first.
11 Feb 2014, 03:30 PM Report Abuse Reply6Like

hi-flyer
Comments (24) |+ Follow |Send Message

As a short, the author will make a killing on this article. Congratulations.
11 Feb 2014, 09:47 AM Report Abuse Reply8Like

jarat44
Comments (30) |+ Follow |Send Message
Author's first article--no name-- could he be twisting the facts? If his claims are true, why has no one else ever reported or leaked the "news"? Big bucks for his "hedge fund business" as described in "his?" profile.
11 Feb 2014, 10:06 AM Report Abuse Reply5Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Ok , I've now read the whole article. Several points but I'm going to jump back and forth because I want to trade. The factory is going to be leased it is NOT. Being funded by NNVC contrary to this article which claims NNVC is paying millions for. That is totally false information. Msecondly don't you think Pfizer etc is going to reap most of the benefits from BIND and thus Ney have sold the future for upfront money which NNVC would rather gamble on tinier tech. Got to go
11 Feb 2014, 10:25 AM Report Abuse Reply3Like

noretreat
Comments (45) |+ Follow |Send Message
This article makes a number of important points about NNVC, but it goes well over the top when it talks of Mr. Erhlich and Dr. Menon. These two are doing outstanding work, rapidly advancing multiple drugs through clinical trials at CTIX. There is a world of difference between the two companies.
11 Feb 2014, 10:34 AM Report Abuse Reply6Like

Kirk Lindstrom, Contributor
Comments (1033) |+ Follow |Send Message
A skeptic might think that one way to get cheap shares in a stock they know is going to be worth $100 a share someday is to pay someone $1000 to run a "hedge fund" managing that money, go short the stock AND THEN write a article trashing the stock.
How do we determine who is right?
To the author, why not use your real name and tell us what country you live in?
Also, how large is your hedge fund and how large is your "short" position in NNVC?
I would not be surprised if I've personally made more money taking advantage of these bear raids to trash stocks down than is in the hedge fund... but I've also had some stocks go under so there is always the risk the author is right.
11 Feb 2014, 10:38 AM Report Abuse Reply6Like

Pump Terminator, Contributor
Comments (5) |+ Follow |Send Message
Author’s reply » There is no price at which we would recommend or purchase NNVC stock.
12 Feb 2014, 11:12 PM Report Abuse Reply2Like

Kirk Lindstrom, Contributor
Comments (1033) |+ Follow |Send Message
So NNVC is at $4.00 and I have a nice gain on the shares purchased at $3.16 thanks to your article.
Did you cover or are you still short?
Also, why didn't you answer my question about using your real name and what country you live in? I've found honest people don't have to hide or avoid direct, easy questions.
19 Feb 2014, 05:29 PM Report Abuse Reply2Like

ansgarjohn
Comments (28) |+ Follow |Send Message
Do some basic research.
I tried calling NanoViricides at 10 am on Friday morning in September 2013. They have an answering machine that doesn't mention the companies name. Also if you check streetview on Google maps, their address seems fishy, no signs and not an office building.
Nanoviricides Contact:
135 Wood Street
Suite. 205
West Haven, CT 06516
USA
Phone No: 203-937-6137
11 Feb 2014, 10:39 AM Report Abuse Reply2Like

Sticking To Facts
Comments (7) |+ Follow |Send Message
I tried calling them as well, just got the anonymous machine. Then the company issued a "non-rebuttal rebuttal" basically saying the article is all lies, etc... but somehow is not able to name any. Not one?
Meanwhile, I found the article far more specific and trustworthy.
Seeking Alpha = 1000
NNVC = zero
11 Feb 2014, 04:02 PM Report Abuse Reply7Like

donpat
Comments (10) |+ Follow |Send Message
Oh, c'mon - give NNVC some sort of rating, a 1 even?
Otherwise you appear as a radical cretin.
RU?
14 Feb 2014, 01:49 PM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
These guys are part of the short cabal. Watch them disappear after the cover you will see no more slamming and sleaziness by them. I bought more on the raid,but shame on them !
19 Feb 2014, 05:12 AM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
As info I am long, I am also apparently a magnet for this kind of trashing, or at least stock I buy are excellent targets for this kind of bashing. This makes stock and company number three, in a month, bummer! I am long RMTI. A company just ended phase 3 with a drug that is now at the FDA's door for an NDA for dialysis patients. Relaces iron much more efficently during dialysis saving mucho money for the payers! Stock was 15 trasher brought it to $10 ish claimed no good results but the chronic kidney meeting just last week or two gave them best in show award for new drug! still waiting and holding on. Second PRAN a possible and currently best shot at,Alzheimer disease cure or at least treatment, attacked a few days ago as not efficacy positive , but the trial was for TOXICITY. Which I'm betting hugely likely to approve as all indications are positive, ala 5 FDA. Safety committee meetings during test and no recommendation to change any protocols and 95% of cohort including placebos elected to go and completed a 12 month extension! Writer claimed data not good enough but the data has not been publicly disclosed, due by end this Q. And now this one, this is a concentrated attack as you can see in he comments to undermine the co. They are either great hoodwinkers d fooling various governments to get in bed with them while only interested in raping and pillaging and yeah building facilities and raising millions to steal. Fooling the FDA. Into orphan drug status, not so easy I'm sure! And yes we are all taking care of ourselves. If they have what they are attempting it is all going to be valued in the billions. I've been involved in several public start ups, you always would rather deal with friends as vendors and outside servers better than cold cash big outsiders. I think it evolves. Anyone else have 2 cents to put into the mix? Welcome to the fight..
11 Feb 2014, 11:18 AM Report Abuse Reply2Like

Mark Koch
Comments (5) |+ Follow |Send Message
Hope you are right smallcap. I too am long and...
I am sick of publicly held opinions held by snipers that do not use a proper name. Stand up and be a man/woman PT. Let's get real. The author is using libelous language and unless he or she can back it up he/she needs to be sued by the injured parties and if possible, prosecuted.
Mark Koch (real name)
11 Feb 2014, 03:45 PM Report Abuse Reply2Like

ansgarjohn
Comments (28) |+ Follow |Send Message
@smallcap sleuth You might like to follow Tony Friedman http://bit.ly/MJ72qh he knows his stuff and has a verifiable track record.
11 Feb 2014, 04:34 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
IsNT this the Tony that is bared from dealing with the NASD and is refused a? license by the SEC
13 Feb 2014, 03:43 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Some fight back some don't my PRAN finally reported the results of one of the two phase 2 studies. Hit all its primary goals on Huntington's disease stock went from $7.25 to $10.10 yesterday. M2 Harvard med school proffers are tweeting about how GOOD. The tests and data are and how encouraging the test results. Stock pre market this AM. Is now up another $.40 . NNVC I hope is going to counter this sliming and you won't have to wait a month like I just did with PRAN. Fight back company !
19 Feb 2014, 05:19 AM Report Abuse Reply0Like

Lorax666
Comments (2150) |+ Follow |Send Message
-- Hit all its primary goals on Huntington's disease
Right. Safety as primary in a PII study? Smoke and mirrors.
19 Feb 2014, 10:08 AM Report Abuse Reply0Like

Trond
Comments (52) |+ Follow |Send Message
I had to laugh at the quote from India New England. This journal evidently said, "The only reason we took it down is the editor is no longer with us and this story caused quite a stir, and we grew tired of all the phone calls"
I can only imagine how distressing it is for a publication's article to cause a stir. And gosh, having to answer the phone! That must be terrible. Maybe they should cease publishing with that kind of reaction.
11 Feb 2014, 12:01 PM Report Abuse Reply1Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
Trond... The article you refer to was taken down after the editor received facts proving it was poorly researched and included erroneous information.
I don't know much about NNVC and how their website is updated, but, Dr Menon is no longer affiliated with them and has never been the one to update the information on the site. He can't be blamed for any errors. The affiliation ended due to too many obligations with CTIX. Go to the CTIX website for accurate background on Dr Menon. http://bit.ly/10rKRJE
Following is a short quote: "Dr. Menon is a trained veterinary surgeon and holds a PhD in Pharmacology from Kerala University. His PhD work focused on anti-folate therapy of various cancers."
I can only imagine how many inaccuracies are in the above article after seeing the ones on a subject I'm familiar with.
11 Feb 2014, 10:12 PM Report Abuse Reply3Like

Pump Terminator, Contributor
Comments (5) |+ Follow |Send Message
Author’s reply » per NNVC's SEC filings Menon is still associated with them.
12 Feb 2014, 11:13 PM Report Abuse Reply1Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
Pump Terminator. I don't know the date the relationship ended, but, it is ended. It should be reflected in the next filings if it hasn't shown up yet and the website hasn't been updated either. Remember, Dr Menon isn't the one updating the site. Check the CTIX site for accurate information on Dr Menon.
13 Feb 2014, 12:49 AM Report Abuse Reply2Like

Hope4Future
Comments (291) |+ Follow |Send Message
Karin / Sharon / whoever, how is it you are the world's greatest defender of CTIX and appear to be so very knowledgeable about their inner workings! You've done one-on-one interviews with the CEO (Leo Ehrlich) and posted them under a pseudonym. CTIX is such a transparent company that they are willing to one-on-one interviews between anonymous bloggers and the CEO! When you called up to ask for the interview, did you say "hey Leo, this is KarenCA/Sharon/ActionJ... and I really want to do an exclusive interview with you? I know you're not Equity Options Guru because it turned out he's a scammer named Tom Meyer who posted under various names on Seeking Alpha and then wrote for Forbes referencing his own articles on SA to support his Forbes opinion. At least you're not that scammer too. Or maybe you are. who knows on this site.
14 Feb 2014, 12:53 PM Report Abuse Reply1Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
I'm more of an investor type these days and started doing a tremendous amount of research on the companies I invest in. I read SEC filings, news, blogs, whatever is available. The interesting thing is why I started writing in the first place. I don't know if you recall, but, SA removed three articles on CTIX that were discovered to be written by the same person. Before they removed them I was disgusted that three different people could put out so much misinformation about a company. None of them even mentioned the ongoing trial at Dana Farber. So, I decided to write something to clarify what the company was doing at that point in time. Someone liked my article and sent it to the CEO.
He knows my full name. I'm not anonymous to him. And, because of having done two interviews I decided to call him after seeing this article to see if there is any relationship at this point in time. He said there is none. I believe him.
I've actually had other opportunities to interview CEO's since I routinely invest in biotech and these CEO's are much more accessible than those of long established companies. Personal things have kept me from it the past few months but my intention is to start writing again in the near future. And, I may start doing those interviews with others. Time will tell.
Think what you like. I certainly understand how one can become jaded in this arena. Good luck in all your trades and life in general.
14 Feb 2014, 02:15 PM Report Abuse Reply5Like

Hope4Future
Comments (291) |+ Follow |Send Message
You must be thrilled that a company with very few resources that has a drug called Kevetrin that you and a few others have touted to be the P53 miracle drug, a multi BILLION dollar opportunity, and another psoriasis drug that you tout will be another multibillion dollar opportunity has recently purchased an antibiotic from a bankrupt company and is using their very scarce resources on this new miracle drug that no one else wanted. You must be thrilled with their brilliant diversification strategy so they will be as big as.... as.... as.... Pfizer, yeah that's the ticket... in ... how long would you say..... hmmmm..... how about 2 years... yeah, that's the ticket? Good luck in your trading :{)
14 Feb 2014, 04:49 PM Report Abuse Reply0Like

rlaakso
Comments (170) |+ Follow |Send Message
Why would you make a statement like that???
14 Feb 2014, 04:53 PM Report Abuse Reply1Like

Hope4Future
Comments (291) |+ Follow |Send Message
what statement. it's called sarcasm.
14 Feb 2014, 05:00 PM Report Abuse Reply0Like

allen_jones
Comments (119) |+ Follow |Send Message
I cannot believe this lasted as long as it did. What sort of company operates for a decade and never moves a single compound beyond a quasi pre-clinical testing.
11 Feb 2014, 12:19 PM Report Abuse Reply5Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Ijit biotechs want a long list?
27 Feb 2014, 01:48 PM Report Abuse Reply0Like

Trond
Comments (52) |+ Follow |Send Message
I am actually curious about this issue: when the author mentions BIND as a great contra example.
I looked up BIND and they switched names and went public less than a year ago. They are already in ph2 for one of their drugs.
I'd be curious to see what their situation was, when they were preclinical. How much the founders of that company burned through of "the public's" money and how much they extracted?
Terminator - want to disclose any of that?
11 Feb 2014, 12:27 PM Report Abuse Reply3Like

troutrise
Comments (37) |+ Follow |Send Message
I took a look at NNVC a week ago. Their approach to fight various diseases is novel and seems to have merit. Before investing I like to see a technology moat or at east enough of a lead that it would be hard catch up. A cursory search of the US patent archives yielded very little under the search terms of the company or " Anil Diwan". The two patents I found were quite specific and, in my opinion, easy to circumvent. Also, the business structure among NVCC, Theracour and Diwan seems peculiar, easily manipulated, and "incestuous". So I stayed away.
11 Feb 2014, 01:25 PM Report Abuse Reply3Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Just reread the co announcement that they raised $20 million ( now holding approx $40 million) and that capital will fund phase 1 & 2 on humans for injectable flucide and also the dengue fever trials. Plus they must have fooled not only the US FDA but also the Europeans as they have orphan drug designation from the European Medical Agency (EMA). This was press released on Jan 21 '14. They claimed they received the funds from "institutions and current stockholders". So are they just recycling the money they loot to put it back in to loot again? Doesn't make much sense to me does it to you pumper dumper! The EMA is the European Agency to "evaluate medicinal products" according to their web site. Its also the agency " responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines". Pretty strong to bother to bluff your way through he FDA. And those guys! You are a manipulating short seller with the morals of?
The more I look the more ridiculous your claims are. I'm going to bed its late in thevAM here in Thailand. Good night all
11 Feb 2014, 01:40 PM Report Abuse Reply4Like

Lorax666
Comments (2150) |+ Follow |Send Message
Orphan drug is in no way an endorsement of any drug. It only is acknowledgment that the sponsor has chosen a small patient population. Nothing more, quoth the raven.
11 Feb 2014, 03:12 PM Report Abuse Reply1Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
Robert0713... There must be scientific rationale to get a drug approved under Orphan Drug regulations. It’s much more involved than simply looking at the patient population. Safety and effectiveness of a drug must be established first.
~~~~~~~~~~
You may want to read up on Orphan Drug regulations. Following are some FDA links on the subject that you may find of interest:
~~~~~~~~~~
Designating an Orphan Product: Drugs and Biological Products
http://1.usa.gov/1g8JC6G
~~~~~~~~~~
Developing Products for Rare Diseases & Conditions
http://1.usa.gov/1bnvbyv
~~~~~~~~~~
Orphan Drug Regulations
http://1.usa.gov/1bnvd9w
~~~~~~~~~~
Btw, I don't hold any NNVC.
11 Feb 2014, 10:37 PM Report Abuse Reply1Like

sheeple123jump
Comments (432) |+ Follow |Send Message
Karin, Are you not interested in owning any NNVC ? even at these prices?
11 Feb 2014, 10:46 PM Report Abuse Reply0Like

KarinCA, Contributor
Comments (883) |+ Follow |Send Message
sheeple123jump...I'll be checking it out again. It's been awhile since I held any.
11 Feb 2014, 11:09 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Thank you for this information it certainly adds credibility to NNVC at a time of stress and misinformation seemingly driven by a band of shorts trying to panic believers and stockholders. So Robert 0713 do you agree with Karin or is your post just bunk to scare folks. Or are you just quoting birds of a feather Raven
12 Feb 2014, 03:27 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
This is not truth it requires hurdles set by the FDA
12 Feb 2014, 03:36 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
This is not truth it requires hurdles set by the FDA
12 Feb 2014, 03:36 AM Report Abuse Reply0Like

Lorax666
Comments (2150) |+ Follow |Send Message
-- Orphan drug designation means that the sponsor qualifies for certain benefits, such as reduced taxes, from the federal government. It does not mean the drug is safe and effective and legal to manufacture and market in the United States.
12 Feb 2014, 10:00 AM Report Abuse Reply1Like

gbstern13
Comments (153) |+ Follow |Send Message
Robert-
You are correct in that Orphan designation does not mean the drug has passed all necessary safety and efficacy thresholds to market. However, there are some thresholds and research data that needs to be submitted and approved by the FDA to receive Orphan status. You make it seem like it's as simple as, "Hey, we've got an idea for a small population drug treatment, can we have Orphan status please?" There is much more to it than that.
While I think there are some interesting points raised in the article about the corporate structure, if the owner's true intent was to defraud investors and enrich himself via shell companies, the time and money required to deal with FDA filings (and European counterparts) would seem counterintuitive to that sole purpose.
13 Feb 2014, 10:12 PM Report Abuse Reply0Like

donpat
Comments (10) |+ Follow |Send Message
Worth $ Millions when approved.
14 Feb 2014, 01:56 PM Report Abuse Reply0Like

sethbru, Contributor
Comments (51) |+ Follow |Send Message
The company issued a PR rebuttal with more to follow and the CEO will be on a radio interview later today. Looks like they are fighting back.
11 Feb 2014, 01:51 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Can't sleep to wired up I think this might be the spark that sets this rocket ship a flight.,If you trashed it to buy big time thanks cause I bot a bunch more . But it's a low nasty business you do. But it's certainly caused a lot of trading today. Put the co on the map. Must look for the release sethbru posted about!
11 Feb 2014, 01:58 PM Report Abuse Reply1Like

ansgarjohn
Comments (28) |+ Follow |Send Message
Have you tried phoning the company?
11 Feb 2014, 04:36 PM Report Abuse Reply1Like

sethbru, Contributor
Comments (51) |+ Follow |Send Message
The PRs are posted at http://bit.ly/MIJFxa
11 Feb 2014, 02:01 PM Report Abuse Reply1Like

timing-is-everything
Comments (1) |+ Follow |Send Message
Ditto, hi-flyer. I was long. I was wrong.
11 Feb 2014, 03:30 PM Report Abuse Reply0Like

HedgeScammer
Comments (7) |+ Follow |Send Message
Folks read this posters comments. He is a very knowledgeable professional in the biotech industry. I agree with him and have requested my law group(on retainer) to sue the hell out of the lying author of this hatchet job!!!
http://bit.ly/1bmIZsR
I wonder if the FDA and all the trial partners know that NNVC is a scam,lmao?
11 Feb 2014, 03:31 PM Report Abuse Reply0Like

Kroneborge
Comments (12) |+ Follow |Send Message
It's actually quite common practice for owners of a company to make sure they keep control of it. These special shares aren't that uncommon and prevents someone else from taking over your company and running it into the ground.
11 Feb 2014, 04:01 PM Report Abuse Reply0Like

Kirk Lindstrom, Contributor
Comments (1033) |+ Follow |Send Message
Interesting that nobody has posted this yet...
NanoViricides, Inc. Responds to Baseless Seeking Alpha Article
February 11, 2014
Dr. Seymour, the founder and Chief Executive Officer of NanoViricides, stated, “We are outraged at this unfounded and intentional attempt at deflating the Company’s stock price. We will have a more detailed response, in the near future, once we determine our options, including all legal action to determine the identity of the author, but we want to assure our shareholders and the market that the Company’s purpose is the same as always - to eradicate life-threatening viruses and increase shareholder value.”
Dr. Diwan, founder, President and Chairman of the Board commented, “This is a shameless attack from someone who neither understands the science nor the development work that has gone into nanoviricides® drug candidates. With very little money we have built a rich pipeline of drug candidates that are now getting closer to the clinic. I have personally taken high risks in making certain that the Company can continue to advance by undertaking the building of a highly specialized cGMP manufacturing facility at a time when NanoViricides did not have sufficient funds to be able to commit to this critical venture. All of the biological testing of our drug candidates is conducted by third parties. We are very happy to note that our drug candidates have been found to be safe and highly effective, and therefore worthy of clinical development.”
Read more here: http://bit.ly/1iYRkly
11 Feb 2014, 04:13 PM Report Abuse Reply4Like

petery
Comments (44) |+ Follow |Send Message
I have learned two things from the documents, all of which I have read. First, there is a lot that needs to be cleaned up at this company. It is a mess. Second, the company's products have block buster potential as admitted by the plaintiff. Let's hope this article helps fix things and the company cleans up its act so it can properly pursue its potential.
11 Feb 2014, 05:06 PM Report Abuse Reply1Like

JeffreyLangBoyd
Comments (663) |+ Follow |Send Message
Would agree with your comments but the article seems to conflict with the key premise of the article that it is a house of cards.
Instead the author of the article appears to either be directly involved in the derivative and demand for document lawsuits or more likely simply being used by that person. I would be o.k. with that if it weren't for the fact that the complaints appear to from a banker who is bothered by the fact that he missed out on the fees associated with earlier stock issuances.
11 Feb 2014, 07:07 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
I'm a holder could you be specific and address your statement that the company is a " mess". Please be specific, thanks.
12 Feb 2014, 03:33 AM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message
you state:
"If the Theracour relationship were terminated or changed for the worse, there would literally be zero technology or IP left with NNVC."

What a joke you are, they have a published agreement in place giving NNVC exclusive rights in perpetuity to a long list of viral applications.
By the way, can you really not even spell correctly the name of the individual that keeps filing the bogus lawsuit? His name is not "Brammel". But then attention to detail is obviously not your strong suit.
Puff
11 Feb 2014, 08:08 PM Report Abuse Reply3Like

Pump Terminator, Contributor
Comments (5) |+ Follow |Send Message
Author’s reply » the contract with Theracour is not without conditions as cited in our article. We recommend you read both our article and the details that are publicly available on the Theracour contracts..
12 Feb 2014, 11:16 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Following the hit comments closely huh, so you and allies can try gas on flames?
13 Feb 2014, 03:46 AM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
The hit job is complete now let's hope the company can explain the present going forward timelines to get the investment community looking to what is about to manifest. The company has 3 different,country governments entities working with or approving of its science so how is it possible that one in the shadows writer can cause such a panic? He should be made to pay the legal bills that are now going to beset the co. I just hope the co puts its going forward plans clearly on the table for all to see.
11 Feb 2014, 08:59 PM Report Abuse Reply3Like

STJ
Comments (256) |+ Follow |Send Message
my error on the spelling, it was linked incorrectly from the lawsuit.
11 Feb 2014, 09:07 PM Report Abuse Reply0Like

silverant
Comments (71) |+ Follow |Send Message
He targeted the easiest group of pigeons in the investing world - star-struck biotech junkies, whose main reason for investing is a dream - they are the ones who sold off and lost some money and positions today.
I wonder what the guy who sold for 2.65 is thinking right now?
11 Feb 2014, 09:38 PM Report Abuse Reply3Like

Robbster
Comments (47) |+ Follow |Send Message
I'm holding my position for now. What a world we live in as developmental biotech investors...
12 Feb 2014, 03:21 AM Report Abuse Reply0Like

Sticking To Facts
Comments (7) |+ Follow |Send Message
Anyone thinking of investing in this stock needs to read the lawsuit first. I'm looking forward to reading the next article in this series.
12 Feb 2014, 04:29 AM Report Abuse Reply0Like

ash187
Comments (222) |+ Follow |Send Message
Did a patent search for the president Anil Diwan. He's named on a few patents which i can't be bothered reading into if they're worth anything but they're all registered to a different company (Allexcel) which has the exact same business address as Nanoviricides. What's hilarious is that Allexcel is registered as a software company (http://bit.ly/1m6uaza). Looks like one massive circlejerk of a company. If it looks like a duck, quacks like a duck...its probably pump and dump scheme using multiple linked companies with the same registered owners
12 Feb 2014, 05:35 AM Report Abuse Reply4Like

ansgarjohn
Comments (28) |+ Follow |Send Message
And Allexcel doesn't mention answer their phone or mention their name in the message either...(203) 764-2036
If you're long with serious money, get in your car and drive to 135 Wood Street
West Haven, CT 06516
12 Feb 2014, 09:30 AM Report Abuse Reply3Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Company is transitioning to new offices according to info I have.
12 Feb 2014, 11:38 PM Report Abuse Reply0Like

Jim Bowie, Contributor
Comments (117) |+ Follow |Send Message
Nice disclaimer on your profile PT. http://bit.ly/1eQ3miF
12 Feb 2014, 09:35 AM Report Abuse Reply1Like

ash187
Comments (222) |+ Follow |Send Message
further research into who's hired at allexcel. Some overqualified 'chemists' such as this guy (http://linkd.in/1eQ70ZZ) which i think is a fake anyway because he's been cited in this 'research' (http://bit.ly/1eQ71x4) which clearly points to the same guy at Allexcel, which was published about a month ago and is a functionally useless research paper in a useless journal.
12 Feb 2014, 10:11 AM Report Abuse Reply1Like

Fall1980
Comments (51) |+ Follow |Send Message
I think it is unfair and misleading to cherry pick Rajesh Pandey's vita like that to cite a paper where he is listed as fourth author on a review in an obscure journal, and ignore, for instance, "Reactivity of (2-alkenyl-3-pentene-1... complexes: preparation of functionalized vinylcyclopropanes and cycloheptadienes" in J. Org. Chem. 2008, 73(18), 7236-7245, where he is first author (http://bit.ly/1nzFf7k). Actually, after reading the article you cite, and looking at the list of the rest of his publications, I am suspicious that his name and affiliation may be attached to the WJPPS article in error. BTW, how did you find that article, I could not using Google and Google Scholar.
14 Feb 2014, 04:30 PM Report Abuse Reply1Like

quattroluvr
Comments (104) |+ Follow |Send Message
I bought this NNVC on advice from a pretty well known newsletter company. Shame on me for not reading the 10K... I DID read it last night and was horrified. The major and multiple conflicts of interest and opportunities for self-dealing for the exec team are worthy of the worst 'New Jersey/Chicago style politicians.' Even if they aren't taking undue advantage, the sheer fact that they have __structured___ their company this way, is appallingly bad mgt practice re the actual conflict of interest and the potential for egregious self-dealing, and enough reason to avoid this team like the plague (pun intended), regardless of whether or not, or how much $$$ execs have 'unfairly taken' to date.) The incestuous STRUCTURE is enough for me to say no, i want out, even if their products and services have technical merit.
That said, I bought low enough I realized a rather hefty 61% profit on NNVC this morning -- before it crashes far lower on some new revelation of exec hanky panky. A BIG THANKS to the author and Seeking Alpha for the 'red flags raising' that got me out with profit before a disaster.
(BTW - This same tech newsletter is infamous imo, for missing similar red flags due to negligence due diligence wise, eg the 'over reliance on a single large (crooked) Chinese customer' fiasco that was American Superconductor, that lost me 96% of my investment overnight. This obvious red flag was not mentioned even once in their buy recco, or many updates).
12 Feb 2014, 12:40 PM Report Abuse Reply1Like

Bobby12345
Comments (19) |+ Follow |Send Message
what newsletter?
12 Feb 2014, 01:15 PM Report Abuse Reply0Like

mkmdude
Comments (4) |+ Follow |Send Message
Please explain Quattro, you mean you are a "Lead-Investor" for a Family Office and you don't read a 10-K before you invest in a small-cap biotech? Please name this newsletter.
12 Feb 2014, 05:47 PM Report Abuse Reply1Like

quattroluvr
Comments (104) |+ Follow |Send Message
Criticism accepted! I did say in my post... 'shame on me for not reading..." I have a day job, lame excuse! Read those 10K's, who needs sleep wink
13 Feb 2014, 01:03 PM Report Abuse Reply0Like

quattroluvr
Comments (104) |+ Follow |Send Message
...oh, and in my defense, ZERO$ of my family clients were in NNVC. This was in one of my smaller personal accounts I use for speculations/micro-cap positions. Client protection I think was the important point you were making implicitly. No harm to clients is a vital priority, agreed. Not reading a 10K on my own account, just a bit lazy maybe wink but no harm no foul for OPM.
13 Feb 2014, 08:36 PM Report Abuse Reply0Like

quattroluvr
Comments (104) |+ Follow |Send Message
answered newsletter question via PM. The editor has changed so I'm giving them the benefit of the doubt for now.
12 Feb 2014, 04:02 PM Report Abuse Reply0Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
@quattroluvr
If it was Patrick Cox and published by Agora, or Tobin Smith, it is just shameless stock promotion. Do some real research on them and Porter Stansberry.
http://bit.ly/1hdf9JN
http://bit.ly/1hdfcoL
12 Feb 2014, 04:59 PM Report Abuse Reply0Like

Mr.Fox
Comments (1) |+ Follow |Send Message
Nice work.
12 Feb 2014, 09:04 PM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
NYSE investigating shorts and so is FINRA These naked attempts to drive a stock down are only effective for an initial burst because people don't do enuf of their own DD. The hurdles this small company has already overcome are impressive. Imagine 3 different governments approving of the science and work being done by eminent scientists on moving this approach forward AND $40 million in the bank to carry on. AND deadly diseases injected into animals that are then treated with NNVC drug candidates and they do not die. We have a winner here, a BIG. Winner in he making!
I think Quattro is part of the bear attack. He says he bot on the advice of a newsletter that he then says is infamous. Who does that? Do any of you?
12 Feb 2014, 11:37 PM Report Abuse Reply4Like

quattroluvr
Comments (104) |+ Follow |Send Message
Hi smallcap sleuth. Quattro here. I am not a 'bear attacker'. I was/am not short NNVC ever, I was not a holder of Puts ever. Until the 2/12 article I was long since a single purchase on May 28th 2013. This NNVC long position was in a small spec-only account of my own money. I have been paying far more attention to other accounts, including my fam clients who i have in much safer, often dividend paying positions. When I read up on NNVC back in spring 2013 I didn't spot the structural issues, and liked the virus related story and upside, for something the world really needs. Pandemic anyone? After that I didn't pay much attention to the position, and I had liquidated any other of the negligent Patrick Cox's newsletter reccos long ago. I thought maybe it was a rare Cox recco that had real upside.
Assuming I'm a bear attacker is both _wrong on the facts and _distracts from alerting other long investors that the CORPORATE STRUCTURE of NNVC created by the exec team is SUFFICIENT REASON to ditch this flakey mgt and stock, imho. Don't fall in love with the bio story, look at the structure, it's just so wrong.
I don't care if they have world-beating technology, or perfect/cloudy IP rights... There are too many other fish in the sea with solid technology and STRUCTURES that aren't _vulnerable to exec self-dealing. Like I said, I don't care about whether the exec actually have/are or NOT doing self-dealing, or are or NOT screwing shareholders... it's the shabby way they've structured it and the risk they _can self-deal, so easily, that justifies an exit. Find a better, clear fudiciary, cleaner structured biotech team is my point.
14 Feb 2014, 11:58 AM Report Abuse Reply2Like

Mirdad
Comments (180) |+ Follow |Send Message
A few weeks ago I emailed NNVC to see if they were having any upcoming trials for chikungunya because a good friend of mine was suffering from the long term effects of this virus. Lo and behold, much to my surprise I received a phone call from Dr Seymour. He was very polite and seemed interested in my friend's condition and offered some recommendations. In over 15 yrs of investing, I've never received the time of day from any executives of any publicly traded company. And get this, I have never bought any shares of NNVC before or after I spoke with Dr Seymour. All I can say, that from my experience Dr Seymour is a stand up guy. There seems to be a lot of complaints about this company not producing any products or revenues for many years. Welcome to the world of biotech. Also, after reading many of the above comments that accuse the reporter (who publishes a damaging article but refuses to use his real name) of writing inaccurate information, well, it seems to me that this critique of this company is not worth the paper it is written on!
13 Feb 2014, 01:09 AM Report Abuse Reply6Like

KBEMN
Comments (110) |+ Follow |Send Message
If anyone is interested in reading another side to these ridiculous claims, see this instablog:
http://seekingalpha.co...
13 Feb 2014, 02:13 PM Report Abuse Reply4Like

epulun
Comments (1) |+ Follow |Send Message
A renewed research contract with a respected lab spells authenticity:
Monday, November 4th, 2013 -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), announced today that theDengueCide evaluation contract has been renewed with Dr. Eva Harris’ Laboratory at the University of California, Berkeley, School of Public Health, Division of Infectious Diseases and Vaccinology.
Dr. Harris is one of the world’s leading experts in dengue. This contract renewal will allow the Company to continue its drug development program for the treatment of dengue.
13 Feb 2014, 03:40 PM Report Abuse Reply2Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Yes clearly they have top level science tech and world class collaborators. Top line scientists don't bother with less than top line solutions to the quests they are on. The renewal says everything you need to know about the drug candidates credibility! There can be NO doubt about the legitimacy of the company and in sifting thru the rebuttals to the piece there is thin if any facts that remain for these fearmongers to stand on to attack the stock..
If the science continues to work as it has so brilliantly on animals (curing deadly doses of deadly diseases) when being exposed to human trials this stock is going to be worth hundreds of dollars a share.
Two more points are that the company's drugs do not enter into the bodies cells so the likely negative side effects are significantly minimized. And secondly the human trials will be shorter than most FDA trials because if you are scheduled to die due to some nasty virus and you don't its rather readily recognized that it worked. Yes if a body is cleared of a disease causing virus it's sort of black or white. I am anxiously awaiting trials. Bring it on Dr Seymour! Lets get the cGMP facility up and approved so we can get into testing and I believe that facility is due in a month or 2.
Lastly the company claims that the master method behind the functioning for each disease can in weeks be adapted to any virus as it is sort of like fooling the virus to think it found its cell target while it really is meeting a deadly mate.
14 Feb 2014, 03:13 AM Report Abuse Reply4Like

petery
Comments (44) |+ Follow |Send Message
You are right on in your analysts. The product is unique because it does not interact with cellular mechanisms, the immune system or other complex chemical pathways in the body. What happens in vitro and in animals should be exactly what happens in humans. We just need to know it is safely cleared fro the body.
15 Feb 2014, 01:24 PM Report Abuse Reply0Like

thomasp2a
Comments (1) |+ Follow |Send Message
a lawsuit against seeking alpha is going to filed. Check NNVC website for it
14 Feb 2014, 09:36 AM Report Abuse Reply2Like

Kirk Lindstrom, Contributor
Comments (1033) |+ Follow |Send Message
It would be a shame for such a good source of negative sentiment for volatile stocks to vanish. I count on it for getting cheap shares with nice gains already from buying the day this article broke.
Yahoo! message boards are filled with anonymous bull crap. Many of us feel the same about a good percentage of the articles here.
An article here by someone admitting he is short and hoping to profit from the stock going down and unwilling to use a real name should be a huge clue to the validity of the arguments.
14 Feb 2014, 10:27 AM Report Abuse Reply0Like

quattroluvr
Comments (104) |+ Follow |Send Message
Thomas - That's an inappropriate assertion. "against Seeking Alpha" the platform to exchange views on stock is just wrong. Be more precise if you mean, 'against bear article authors'. Seeking Alpha is too valuable a platform to everyone. Who should be the bear police at Seeking Alpha?? What would be the criteria? Being bearish on stocks Thomas is in love with?
15 Feb 2014, 10:35 PM Report Abuse Reply0Like

william macdonald
Comments (17) |+ Follow |Send Message
Very interesting article with many interesting and varied comments; a classic clash of unsubstantiated views. Hope the article stays up.
14 Feb 2014, 10:42 AM Report Abuse Reply0Like

donpat
Comments (10) |+ Follow |Send Message
if it stays up - NNVC wins for libel against SA.
If pulled - I guess NNVC will drop it against SA - not sure about that. But Mr Pump Terminator will have to change his tune. Or lose BIGTIME.
All IMHHO.
14 Feb 2014, 02:17 PM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Forget changing his tune he already chose his destiny ! He shorted bombed the stockholders and deserves to be shafted by the company and their attorneys. FOR MONEY, DISGORGE THE PROFITS THAT HE STOLE. A threat of jail time would also be deserved by his immoral behavior! He did shake out the weak holders so now when the company puts out its side get ready for atrip to NEW HIGH LAND
27 Feb 2014, 05:38 AM Report Abuse Reply1Like

donpat
Comments (10) |+ Follow |Send Message
Article is still here - youse guys got balls!
Maybe much less money shortly.
14 Feb 2014, 01:44 PM Report Abuse Reply0Like

donpat
Comments (10) |+ Follow |Send Message
I dunno, I kinda liked SA before this NNVC bear raid. Now I think they are loose cannons who will print anything without any checking.
Their Tekmira stuff is top notch. Of course, I own it and the reporter likes I. I guess that says it all.
I own NNVC and this reporter - Pump Terminator - sure doesn't like it. So..there you have it.
Will be a helluv an interesting court case!
14 Feb 2014, 02:02 PM Report Abuse Reply0Like

rh12297
Comments (16) |+ Follow |Send Message
I for one will watch this situation play out. Only time will tell how this company will eventually fare.
14 Feb 2014, 04:27 PM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
I also like SA but it is a vehicle, and an effective one for misinformation used by bear raiders! I've had the misfortune of having had 3 companies and stock positions attacked by what I would term flimsy sleazy articles that served to trounce share values in the last month or two. PRAN still being wounded unfairly I think and RMTI a bit back as not having good phase 3 data, even tho both of these companies haven even RELEASED. The data ! RMTI just now recovering as the info is out ( not the FDA data but overview as they finished the phase 3) it is now rallying. So take the hit and wait for the recover. I'm glad NNVC is fighting back, the other 2 just foolishly took punches to the face and gut and didn't respond.
NNVC management IS. Stockholder friendly !
15 Feb 2014, 12:16 AM Report Abuse Reply1Like

ansgarjohn
Comments (28) |+ Follow |Send Message
I don't understand why it is a problem when you are long on a stock that the price goes down. Isn't that just a wonderful chance to buy more? "Whether it's socks or stocks, I like to buy when things are marked down." WEB .
Personally I wouldn't invest in Nanovoricides because they don't even have an answering machine with their name on it. Has anyone here actually visited their laboratories? Etc. It is also outside my circle of competence and the people who know their stuff ( high ranking CAPS players at Fool.com ) , don't like it.
16 Feb 2014, 09:20 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Make contact if you want by responding to the investor relations folks listed at the end of company releases. Ansgar you should have already covered your short, why are you still here. Are you the good guys police? Do you attack companies that you have no financial interest in? Could you explain yourself and your posts please! Thanks
16 Feb 2014, 10:43 AM Report Abuse Reply0Like

ansgarjohn
Comments (28) |+ Follow |Send Message
Hi SmalIcap sleuth. I did contact the IR folks at the end of the company release by phone, they said: "We're just a PR company, we don't know anything about Nanoviricides". I am not short this company, I'm clueless about biotech. My question is: If you think the stock is worth more than the current market price, why complain when in effect you can now buy a dollar for fifty cents? Falling stock prices are the best way to make money: http://bit.ly/1oGXevZ
17 Feb 2014, 08:30 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Actually RISING. Stock prices are the best way to make money, unless you are short. You see if you put $50,000 in a stock and it goes down you actually lose money, unless you are a short, understand?
23 Feb 2014, 11:47 AM Report Abuse Reply0Like

Magnus1
Comments (1) |+ Follow |Send Message
http://bit.ly/1f4WhLj
16 Feb 2014, 09:10 PM Report Abuse Reply2Like

STJ
Comments (256) |+ Follow |Send Message
So much for that < $1 target. Thanks for the cheap shares...
19 Feb 2014, 02:44 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Check out Magnus1 two above
20 Feb 2014, 03:17 AM Report Abuse Reply0Like

Old Turk
Comments (17) |+ Follow |Send Message
I was long NNVC, believing it to have amazing potential with a novel concept. I am disappointed to hear that Dr. Diwan has only two relevant patents, both easily sidestepped. Now I wonder how Dr. Diwan can conjure up multiple unrelated ligands at the drop of a hat, while other companies involve dozens of medicinal chemists with supercomputers to do the same thing for just one. A year or two ago, I called Dr. Seymour to complain about how thinly spread out the company's efforts seemed to be (flu, HIV, rabies, ebola, etc.) without a focus on one entity to drive the company's fortunes in human clinical therapeutics. He was the chummiest of all individuals with whom I have ever had the pleasure of talking, and said that he also graduated from Columbia's medical school a few years ahead of me. Today I became suspicious and called the alumni office, to find that there are no records of a Eugene Seymour having ever graduated from Columbia University's College of Physicians and Surgeons. Further, I cannot find a curriculum vitae for Dr. Seymour anywhere on the NNVC website. Ladies and Gentlemen, I have been conned twice before, and I am terribly afraid that NNVC is the third time.
24 Feb 2014, 01:10 PM Report Abuse Reply3Like

STJ
Comments (256) |+ Follow |Send Message
Nice try.

Eugene Seymour, MD, MPH's Overview
Current Chief Executive Officer at Nanoviricides.com
Education Columbia University College of Physicians and Surgeons
Baylor College of Medicine
David Geffen School of Medicine at UCLA

Second, the patents are very encompassing and won't be able to be circumvented --

http://bit.ly/1c1ZFGx

Third, if you understood the science here you would know how Diwan recently whipped up a new solution for the MERS virus in a couple of weeks which will soon be tested by the English govt at Public Health England, also at Viroclinics (of Erasmus fame and a world renowned organization), as well as at LRRI. I suggest a little research before you post a bunch of factless conjecture.
24 Feb 2014, 03:25 PM Report Abuse Reply0Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
@Old Turk.
Thank you for posting that. It is a great example of REAL due dililgence. I just called Columbia to confirm, you are 100% correct. This makes two NNVC execs who have lied about their education.
Krishna Menon was the first. He did not go to Harvard.
Eugene is now the second.
Birds of a feather....
24 Feb 2014, 03:39 PM Report Abuse Reply2Like

STJ
Comments (256) |+ Follow |Send Message
Really? What phone number did you use?
24 Feb 2014, 05:16 PM Report Abuse Reply0Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
@ STJ - The one on the Columbia CPS website. Try using Google sometime.
And check out this piece by Teri Buhl....NNVC lab is subject of a foreclosure case in Connecticut court...
http://bit.ly/1c2jg9x
24 Feb 2014, 05:33 PM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message
Please post the number you called so we can all verify independently. (Prediction - you won't do it because you are full of crap). Teri Buhl? You must be joking. She also said Dr. Seymour was a veterinarian. Direct evidence of the quality of her work... journalistic GARBAGE. Maybe she meant vegetarian LOL! She likes to refer to a lawsuit that has been dismissed 4 times now....thrown out in 4 different jurisdictions as being without merit. Plaintiff's attorney even asked to withdraw on the last attempt. Why I wonder? Obviously it's a bogus case you can file in the frivolous category. Maybe he will file it a 5th time.....
This is too funny. I am smelling desperation among the shorts as they have been unsuccessful in keeping the stock down and obviously have not yet covered. They are pounding the blatant paid stock manipulation site IHUB as hard as they can, to no avail.
http://bit.ly/1fOG4F4
24 Feb 2014, 06:24 PM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message

$17K.... seriously?
LOL, the company has $38M cash.
What a calamity, OMG! Certain devastation and destruction for the company! Delist them immediately!
"but no official lien’s have been filed against the property yet in Shelton."
Oh.... of course not... could it be more bogus journalistic garbage from Teri Buhl?
24 Feb 2014, 06:56 PM Report Abuse Reply0Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
@STJ
If longs are too lazy to do basic research, that is not my problem.
24 Feb 2014, 07:11 PM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message
Prediction confirmed, too funny!
24 Feb 2014, 07:58 PM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message
By the way, Buhl writes her articles while she is in prison...I can understand the difficulty of doing real research in there --
http://bit.ly/1pmTBM6
25 Feb 2014, 12:27 AM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message
LOL... Diwan just filed a form 4.... Insider purchase of 50,000 shares.
Must be a scam....
It was a nice try guys but your lies have been conclusively exposed.
Desperation in the air....
24 Feb 2014, 07:12 PM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
You better run for the basement to hide from your short margin call. So you LOL because the Chair risks $150,000 makes a short term profit which he then LEGALLY must turn back to the company, WHICH HE DID $83,000 and you have the insane nerve and gall to call that a scam. And conclusively exposed and desperate scam. Why don't you try to make an honest buck STJ, you're a pathetic manipulator deserving a nasty comeuppance, karma gonna get YOU
27 Feb 2014, 05:46 AM Report Abuse Reply0Like

Old Turk
Comments (17) |+ Follow |Send Message
Telephone number for Alumni Office of Columbia University's College of Physicians and Surgeons is 212-305-1472. FYI, I am neither long nor short NNVC. BTW, a true curriculum vitae states exact time periods for training, position held, and institution & degree awarded; "Baylor College of Medicine" and "David Geffen School of Medicine at UCLA" don't do much for me.
25 Feb 2014, 09:14 AM Report Abuse Reply2Like

STJ
Comments (256) |+ Follow |Send Message
Old Turk -
He is an alumni of the Baylor College of Medicine, class of '65 (713) 798-4054. You don't get alumni records on someone who attends a particular school but does not get a degree there. Teri Buhl is a very poor source of information. In fact, I would call her a fraud, as few of her "facts" ever check out the way she presents them.
25 Feb 2014, 12:53 PM Report Abuse Reply1Like

Old Turk
Comments (17) |+ Follow |Send Message
STJ, I did call Baylor, and you are correct: Dr. Seymour was indeed awarded an M.D. degree in 1965. And Baylor is a first rate place. Nonetheless, I have to wish you the best with this group of individuals, as I suspect that a management that doesn't hold annual meetings, that holds a majority of the voting shares and that controls the flow of funds to other closely held entities (per Pump Terminator) won't have the welfare of other NNVC stockholders at the top of its priority list. I await publication of NNVC's FluCide results in humans in a peer-reviewed journal. If the results are as predicted by Drs. Diwan and Seymour, this technique will represent a major step forward in medical care. If the preclinical results have been fudged by the good Dr. Menon (remember the painted mice at Memorial Sloan Kettering?), it will only mean that NNVC wasn't the place to be. I still admire the novel concept of letting viruses self-destruct on nanospheres laced with appropriate ligands.
The generic concept of nanospheres sporting ligands is not broadly patentable; there are many such products already in production for other purposes. A very specific ligand can find a patent, but these products are of such high molecular weight that an easily engineered small change could seek its own patent.
If I were the FDA, I would insist on duplicate animal studies done in a truly independent laboratory prior to allowing human trials. And I would insist on a squeaky clean inspection of the cGMP facility that would manufacture the therapeutic product.
I tip my hat to Drs. Seymour, Diwan and Menon for bringing such excitement to the field of medicine. I just wish that they didn't look like such a den of thieves.
25 Feb 2014, 04:36 PM Report Abuse Reply1Like

STJ
Comments (256) |+ Follow |Send Message
Old Turk -
1. They have held annual meetings for the last 2 yrs.
2. Diwan's interests are very much aligned with those of NNVC shareholders. TheraCour's IP is not worth much without a clear path to commericalization. NNVC is that clear path. If something happened to that realtionship Diwan would lose valuable time to market and without the financial rescources of NNVC he would have to start over with fund raising. Who would trust him at that point if he had just pulled the rug somehow on NNVC? The issue raised there just does not survive a common sense analysis. And now it looks like NNVC may well purchase the new manufacturing plant which, if it happens, would further distance Diwan from market success in the event of problems with that realtionship (a relationship which by the way is spelled out very clearly by agreement, and which only allows termination for material breach with 90 days to remedy).
3. Data fudged by Menon?? How about the results from USAMRIID (Ebola), Dr. Gus Kousoulas at LSU (HSV), Dr. Eva Harris at Berkeley(Dengue).... were those all fudged too? Not to mention they are currently lined up for testing with 3 world class organizations - Viroclinics, Public Health England and LRRI.
4. They were issued very broad application of their key patent as can be seen here -
"The US Patent has been allowed with a very broad range of claims to a large number of families of chemical structure compositions, pharmaceutical compositions, methods of making the same, and uses of the same. The disclosed structures enable self-assembling, biomimetic nanomedicines. NanoViricides, Inc. holds exclusive, perpetual, worldwide licenses to these technologies for a broad range of antiviral applications and diseases."
"It is rewarding to see that the US Patent and Trademark Office (USPTO) recognized the novelty and the broad utility of the entire ‘pi-polymer’ class of materials as defined by the inventors, and granted a patent with sufficient scope to protect the whole of the invention, for all foreseeable pharmaceutical applications, including the nanoviricides® anti-viral substances,” said Dr. James Demers, PhD, JD, now with Gotham Patent Services LLC, who represents the inventors before the USPTO and directs the international patenting effort. He further added, “The application was drafted so as to describe and claim Dr. Diwan's invention, on which the nanoviricides® technology is based, as broadly as possible, and we anticipate that other countries around the world will also grant claims similar to those allowed by the USPTO.”
http://bit.ly/1mFTVqq
25 Feb 2014, 05:15 PM Report Abuse Reply2Like

Old Turk
Comments (17) |+ Follow |Send Message
STJ, I appreciate all of your information, and it would be wonderful to find that I have not been conned a third time. You are certainly an elegant spokesperson for NNVC. I await results of clinical testing with great interest.
25 Feb 2014, 05:41 PM Report Abuse Reply0Like

rlaakso
Comments (170) |+ Follow |Send Message
Old Turk,
Hopefully the "third time is a charm" for you and the rest of the NNVC shareholders!!
25 Feb 2014, 06:00 PM Report Abuse Reply0Like

STJ
Comments (256) |+ Follow |Send Message
Old Turk,

No problem, sometimes it is hard to discern the thoughtful posters such as yourself from the bashers with an agenda that are great at misleading and distorting such as Teri Buhl and the author of this Seeking Alpha article (if indeed they are separate entities).

Let me add #5 to the above -

5. If it is such a "den of thieves" why would a Director (Dr. Boniuk) invest $7M in the company? By the way, Dr. Boniuk first learned of the company through his sister, Dr. Vivien Boniuk (another independent tester), who performed animal studies on the Company’s drug candidates for adenovirus and herpes virus infections of the eye. The article implied that this was another inside job since she is related to a board member, when in fact it is completely the opposite.... she introduced her brother to the company as a direct result of being impressed with the science. That is very typical of the distortions presented throughout the SA article.
http://yhoo.it/1ehf9oQ

I would very much encourage you to stick with facts and not rely too much on agenda driven B.S. from the likes of Teri Buhl and Pump Terminator.

Happy investing.
25 Feb 2014, 06:03 PM Report Abuse Reply1Like

Biotech Dude
Comments (11) |+ Follow |Send Message
It doesn't matter who else got suckered in. Mark Cuban also bought $12m of JCP stock when JCP was ~$12.
http://bit.ly/1eiUYXI
26 Feb 2014, 03:19 AM Report Abuse Reply0Like

Biotech Dude
Comments (11) |+ Follow |Send Message
I thought about investing in NNVC a few weeks ago. Then I noticed that Diwan Anil had been treating his company like a personal ATM, selling his shares on a weekly basis and pocketing the money:
http://stks.co/r01wv
Then I wasn't impressed by their website. It's pretty bush league, imho:
http://bit.ly/1prTuyI
I'll consider this letter/litigation a third strike.
There are other biotech startups that are just as promising and with much less baggage.
26 Feb 2014, 03:54 AM Report Abuse Reply3Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Please, PLEASE name the other equally promising companies! I want to invest in them too!
27 Feb 2014, 02:10 PM Report Abuse Reply0Like

Biotech Dude
Comments (11) |+ Follow |Send Message
below are other stocks i like. these ones may not have the enormous upside of NNVC, but these are substantially lower in risk, imho. their current prices are not necessary great entry points, but i've been building investments in these over time.
PRAN
MACK
CPRX
EPZM
PTLA
btw, so it sounds like you are not concerned about the insider selling history at NNVC? that was a huge red flag for me.
09 Mar 2014, 03:03 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Uh PRAN is lower in risk? Pass that dubie dude!
14 Jun 2014, 02:22 PM Report Abuse Reply2Like

Sticking To Facts
Comments (7) |+ Follow |Send Message
Ah yes, "painting the mice". Here's the answer to the claim "They're researchers! They have PhD.'s! They would never twist any research!": http://bit.ly/MAodtV
Most of the "research" for NNVC has come from Krishna Menon, who lied about his Harvard doctorate, inventing drugs for Eli Lilly, and God knows what else.
Step carefully.
28 Feb 2014, 01:15 AM Report Abuse Reply1Like

ConspiracyTheory
Comments (1) |+ Follow |Send Message
Just so you'll know who DIDN'T post this article, see http://bit.ly/1jN5lEe
03 Mar 2014, 06:28 PM Report Abuse Reply0Like

ansgarjohn
Comments (28) |+ Follow |Send Message
People read the SEC quarterly filings and annual reports. If you don't understand them, don't invest. Read "The Intelligent Investor" or "Superinvestors of Graham and Doddsville"
>>THINK & Do the math. <<
This is classic "Wolf of Wallstreet" pump and dump. You are being taken to the cleaners: NNVC) Acquisition In Review" claims that an anonymous source informed the author that an unidentified entity is "intent on acquiring NanoViricides" and that this phantom entity valued the Company "between 2.5 to 4.5 billion dollars".
The author has not contacted any of the Company's executives prior to this posting, nor has Seeking Alpha attempted to verify any portion of the story with the Company.
The Company has no knowledge of being an acquisition target, and has not had any discussions whatsoever of such nature with any parties. Eugene Seymour, MD, MPH, co-founder and Chief Executive Officer of NanoViricides, said "We find it odd that Seeking Alpha would publish one story claiming the Company has no value and a second claiming that it is about to be acquired for possibly up to $4.5B."
The Company provides information regarding its achievements, major corporate events, as well as business strategy, via its press releases, the quarterly and annual reports, and other SEC filings such as the current reports. The Company advises our investors and shareholders to obtain their information from these authentic sources, and perform due diligence based on credible and authoritative sources. The Company further advises our shareholders and investors that they should not rely on false and baseless statements from unknown and phantom entities, such as this post, as well as the prior post by an admitted short seller, both published on the Seeking Alpha website. The Company has filed an action in the Supreme Court of the State of New York to compel Seeking Alpha to disclose the identity of the person who wrote and published a defamatory, malicious, and libelous article about the Company on February 11, 2014, on the Seeking Alpha website, as previously reported.
10 Mar 2014, 09:36 AM Report Abuse Reply1Like

SAuser007
Comments (7) |+ Follow |Send Message
NNVC has been verified long ago not to be scam, cheat or fiddle of a company. Scientific reference books have explained and delineated the fundamentals and legitimacy of NNVC therapeutic advancements (ref - CRC publication Bionanotechnology II ISBN -10: 143980463X).
Institutional investors have made review and purchased shares after having demonstrated acceptance to the NYSE/AMEX. (Ref - Vanguard, Goldman Sacks, Deutsche Bank, et.al.)
Working within the pharmaceutical industry protocols to perform in vitro and later, animal testing, prior to human phases, NNVC has been documented to have had excellent success in both. (Ref – H5N1 & Rabies at the National Institute of Hygiene and Epidemiology in Hanoi, Ebola studies with the United States Army Institute of Infectious Diseases, Epidemic Kerato-Conjunctivitis EKC, anti-Herpes clinical study with THEVAC and Herpes Simplex Virus HSV with Dr. Rosenthal at NEOMED, anti-HIV therapeutics testing with the University of California in addition to KARD Scientific, Dengue Fever tests with Dr. Eva Harris at the University of California, Berkeley, et.al)
The majority of all testing has reported excellent efficacy against the viral types targeted, with no apparent toxicity issues. In proceeding with the normal course of new drug development the FDA granted a pre-IND meeting, which upon being held gave guidance for facility and testing requirements to proceed to first human phase testing. After much effort, NNVC is currently finalizing the facility and preparing for such testing. The FDA and the European medical agencies were also impressed enough to grant NNVC’s Denque Fever anti-viral an orphan drug designation.
The Chair Professor of Ophthalmology at Baylor College of Medicine, and a Director of the Company, was asked why he invested a total of $7M ($7,000,000.00 USD) in NNVC during the 2013 calendar year. His answer was, “As I became familiar with the technology and the various on-going programs that the Company has, it became apparent that the potential was nothing short of amazing”.
It is possible that as a director, he could have some bias, but it is the writer’s understanding that he was originally made aware of the company by a family member that was impressed by the testing she was doing on one of the company’s anti-viral compounds. The point however, is that this well respected doctor, doctors and institutions in other countries, Dr. Harris, Dr. Rosenthal, as well as others, including financial institutions like Vanguard and Goldman, including the FDA, find NNVC credible and worthy of note and respect due.
It is in the writer’s opinion, that if some person, or group puts forth the suggestion that NNVC is a company built upon a scam or a fraud, or is a ‘snake oil’ stock, that their statements or actions are more apt to be based on deceitful ulterior motives designed to promulgate their own scam or fraud, however large or small, than based on the reality of the company or its technology.
It is the writer’s opinion that from a developmental company standpoint and from an industry comparative and historical perspective, NNVC has shown good stewardship of funding by achieving excellent efficacy results for the total invested dollar value to date. It would also be naïve of the writer to assume no missteps have been made and/or clear skies lie ahead. Like all companies, NNVC has been presented with its own set of corporate, technical, business and legal issues. Some likely brought about by their own mistakes or imperfect actions while others made by the assortment of those outside with their own agendas, good or bad. So far though, NNVC appears to have managed their funds effectively to be on the doorsteps of human trials of a potential game changing anti-viral therapeutic product. For that they should be commended.
It is important for all investors to do their own due diligence. It is best to avoid tendencies blindly follow or blindly assume accuracy and legitimacy of positive or negative commentary. It is also critical to understand one’s risk level and beware of misinformation. Recognize that not all misinformation is intentional, while other cases are indeed malicious and/or manipulative in nature.
The writer currently maintains a small equity position in NNVC common stock and as such could be suspected of bias. While not in the medical or pharmaceutical field, a background in science and engineering, including chemical process R&D experience, has been of immense help to the writer in recognizing true technical merit in areas investigated over the last 30+ years. It is a humble opinion that NNVC has a valuable new therapeutic platform and would be a loss to humanity if it were to ultimately be unsuccessful. It is also a humble opinion that NNVC will have headwinds by the relentless capability of the business and investing world to put forth a nearly endless list of obstacles to almost any endeavor, regardless of the underlying technology, worth, or legitimacy. All said and considered, it is the writer’s opinion NNVC is BUY in the speculative biotech equity category.
21 Mar 2014, 09:51 AM Report Abuse Reply5Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Gee I like the above analysis sorry it didn't appear on day one of the articles publication.
26 Mar 2014, 06:27 AM Report Abuse Reply0Like

BuyersStrikeWP
Comments (215) |+ Follow |Send Message
NanoViriScam exposed in the new issue of the NY Observer
http://bit.ly/PPsMSL
29 Apr 2014, 09:01 PM Report Abuse Reply1Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
I assume you in league helped plant this attack. Or are you just some wonderful Good Samaritan policing all the stock markets in the US to question any and all bear raid attack pieces. If so thanks ever so much looked for your up listing when the new saints were posted last weekend by the Vatican. Missed your name!
01 May 2014, 05:23 AM Report Abuse Reply0Like

smallcap sleuth
Comments (260) |+ Follow |Send Message
Tempest in a tea cup. Look at the power pointer sensation on the company's web site.
08 Jun 2014, 05:55 PM Report Abuse

"Who would claim to be one who was not?"
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist